Audio By Carbonatix
Uganda will begin human trials of a Covid-19 vaccine in November, the Daily Monitor newspaper reports quoting ministry of health officials.
The vaccine, called Self Replicating RNA, has been developed through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK.
The head of a presidential taskforce on epidemics, Monica Musenero, is quoted as saying the first trial will be conducted on 10 Ugandans.
If successful, a second trial will involve about 100 to 200 people followed by a final trial of between 1,000 and 3,000 people, she said.
The bulk of the project is being financed by the UK university.
The East Africa country has to date confirmed more than 7,000 coronavirus cases and 75 deaths.
Latest Stories
-
President Mahama breaks ground for modern 24-hour market in Asesewa
5 minutes -
Video: Daniel Kofi-Kyereh ranks Andre Ayew above Essien and Appiah in blind ranking game
10 minutes -
Mensa Otabil launches new book, ‘Leading the Church’, emphasizes governance and leadership transition
1 hour -
Gov’t considers absorbing Western Rail Line reconstruction under Big Push Programme
3 hours -
Don’t store bread beyond four days – Baker advises consumers
4 hours -
Ghana-Korea trade hits $380 million amid growing cultural, investment ties
5 hours -
Why Ghana’s anti-corruption watchdogs are being dismantled — And the Supreme Court may seal their fate
5 hours -
Haruna Iddrisu vows to hike teacher recruitment numbers
6 hours -
First batch of 2026 Ghanaian pilgrims depart Tamale for Mecca
7 hours -
Police dismantle robbery gang in Upper East; 4 in custody, 2 dead during operation
7 hours -
Joseph Opoku’s late strike caps impressive run for Zulte Waregem
7 hours -
Multimedia Egg Market extended to today, Saturday, May 2
8 hours -
Prime Insight to tackle power woes and BoG loss debate this Saturday
8 hours -
Prince Amoako Jnr scores in Nordsjaelland draw against Brøndby
8 hours -
US to cut troop levels in Germany by 5,000 amid Trump spat with Merz
9 hours